MageBio
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Chinese API and intermediate manufacturer providing custom synthesis services for pharmaceutical companies worldwide.
Oncology
Technology Platform
Custom chemical synthesis and process development for pharmaceutical intermediates, with capabilities spanning lab-scale to commercial production.
Opportunities
Growth in outsourcing of chemical synthesis by pharmaceutical companies, particularly for complex oncology targeted therapies and novel small molecule drugs requiring specialized intermediates.
Risk Factors
Intense competition from larger Chinese and international CDMOs, regulatory challenges in pharmaceutical ingredient manufacturing, and dependence on pharmaceutical industry R&D spending.
Competitive Landscape
Competes with Chinese CDMOs like WuXi AppTec and Pharmaron, differentiating through focus on novel chemical intermediates for cutting-edge therapies and flexible scale capabilities.